Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohort.
Saved in:
| Title: | Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohort. |
|---|---|
| Authors: | Kometas, Marisa L.1 (AUTHOR), Hoff, Fieke W.1 (AUTHOR), Hyak, Jonathan2 (AUTHOR), Irizarry-Gatell, Vivian2 (AUTHOR), Marinos Velarde, Alejandro2 (AUTHOR), Jackson, Clayton2 (AUTHOR), Anderson, Julia2 (AUTHOR), Kalkan, Fatma Neslihan2 (AUTHOR), Ramakrishnan Geethakumari, Praveen2 (AUTHOR), Alvarenga Thiebaud, Julio2 (AUTHOR), Chen, Weina2 (AUTHOR), Weinberg, Olga K.2 (AUTHOR), Cantu, Miguel D.2 (AUTHOR), Collins, Robert H.2 (AUTHOR), Chung, Stephen S.2 (AUTHOR), Madanat, Yazan F.2 (AUTHOR) Yazan.Madanat@UTSouthwestern.edu |
| Source: | Leukemia & Lymphoma. Jul2025, Vol. 66 Issue 7, p1245-1253. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
